首页> 外国专利> METHOD FOR PREDICTING EFFICACY OF COMBINED TREATMENT OF PATIENTS WITH RECTAL CANCER BASED ON ACCOUNTING FOR SUPEROXIDE-GENERATING ACTIVITY OF NEUTROPHILIC GRANULOCYTES

METHOD FOR PREDICTING EFFICACY OF COMBINED TREATMENT OF PATIENTS WITH RECTAL CANCER BASED ON ACCOUNTING FOR SUPEROXIDE-GENERATING ACTIVITY OF NEUTROPHILIC GRANULOCYTES

机译:基于嗜酸性粒细胞过氧化物生成活性的直肠癌患者联合治疗疗效预测方法

摘要

The method for predicting the efficacy of the combined treatment of the patients with rectal cancer comprises the assessment of the organic transformation in the body. The neutrophilic granulocytes are isolated from the venous bloos following the last fraction of the neoadjuvant chemoradiotherapy. In the isolated cells, the rate of the generation of superoxide radicals by NADP·H-oxidase is measured. The rate below 0.31 nM/105 cell·min is considered as a favorable prognostic factor of survival of the patients with high level of tumor chenmoradiosensitivity. The rate exceeding such value is considered as a negative prognostic factor of survival.
机译:预测联合治疗直肠癌患者疗效的方法包括评估体内的器官转化。在新辅助放化疗的最后一部分之后,从静脉血中分离出嗜中性粒细胞。在分离的细胞中,测量NADP·H-氧化酶产生的超氧化物自由基的速率。低于0.31 nM / 105 cell·min的比率被认为是高水平肿瘤化学放射敏感性患者生存的预后因素。超过该值的比率被认为是生存的阴性预后因素。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号